David Altshuler

Insider Reports History

Entity
Individual
Location
C/O Vertex Pharmaceuticals Incorporated, 130 Waverly Street, Cambridge, MA
Signature
/s/ Christiana Stevenson, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by David Altshuler:

Stock Role Class Num Shares Value Price $ Report Date Ownership
VERTEX PHARMACEUTICALS INC / MA EVP, Chief Scientific Officer Common Stock 25.8K $12.4M $478.56 Nov 15, 2024 Direct

Insider Reports Filed by David Altshuler

Symbol Company Period Transactions Value $ Form Type Date Filed Role
VRTX VERTEX PHARMACEUTICALS INC / MA Nov 15, 2024 1 -$7.18K 4 Nov 19, 2024 EVP, Chief Scientific Officer
VRTX VERTEX PHARMACEUTICALS INC / MA May 15, 2024 1 -$23.3K 4 May 17, 2024 EVP, Chief Scientific Officer
VRTX VERTEX PHARMACEUTICALS INC / MA Feb 23, 2024 2 -$3.52M 4 Feb 27, 2024 EVP, Global Research and CSO
VRTX VERTEX PHARMACEUTICALS INC / MA Feb 21, 2024 1 -$1.27M 4 Feb 23, 2024 EVP, Global Research and CSO
VRTX VERTEX PHARMACEUTICALS INC / MA Feb 16, 2024 3 -$4.46M 4 Feb 21, 2024 EVP, Global Research and CSO
VRTX VERTEX PHARMACEUTICALS INC / MA Feb 9, 2024 2 -$2.21M 4 Feb 13, 2024 EVP, Global Research and CSO
VRTX VERTEX PHARMACEUTICALS INC / MA Feb 6, 2024 3 $0 4 Feb 8, 2024 EVP, Global Research and CSO
VRTX VERTEX PHARMACEUTICALS INC / MA Nov 15, 2023 1 -$7.03K 4 Nov 17, 2023 EVP, Global Research and CSO
VRTX VERTEX PHARMACEUTICALS INC / MA Aug 9, 2023 1 -$21.8K 4 Aug 11, 2023 EVP, Global Research and CSO
VRTX VERTEX PHARMACEUTICALS INC / MA Feb 24, 2023 4 -$2.37M 4 Feb 28, 2023 EVP, Global Research and CSO
VRTX VERTEX PHARMACEUTICALS INC / MA Feb 17, 2023 5 -$2.27M 4 Feb 22, 2023 EVP, Global Research and CSO
VRTX VERTEX PHARMACEUTICALS INC / MA Feb 14, 2023 6 -$1.91M 4 Feb 16, 2023 EVP, Global Research and CSO
VRTX VERTEX PHARMACEUTICALS INC / MA Feb 10, 2023 6 -$4.24M 4 Feb 14, 2023 EVP, Global Research and CSO
VRTX VERTEX PHARMACEUTICALS INC / MA Feb 6, 2023 8 -$154K 4 Feb 8, 2023 EVP, Global Research and CSO
VRTX VERTEX PHARMACEUTICALS INC / MA Feb 1, 2023 3 $0 4 Feb 3, 2023 EVP, Global Research and CSO
VRTX VERTEX PHARMACEUTICALS INC / MA Nov 15, 2022 1 -$10.5K 4 Nov 17, 2022 EVP, Global Research and CSO
VRTX VERTEX PHARMACEUTICALS INC / MA Nov 7, 2022 9 -$151K 4 Nov 9, 2022 EVP, Global Research and CSO
VRTX VERTEX PHARMACEUTICALS INC / MA Aug 8, 2022 7 -$137K 4 Aug 10, 2022 EVP, Global Research and CSO
VRTX VERTEX PHARMACEUTICALS INC / MA Jul 19, 2022 8 -$2.06M 4 Jul 21, 2022 EVP, Global Research and CSO
VRTX VERTEX PHARMACEUTICALS INC / MA Feb 24, 2022 5 -$3.12M 4 Feb 28, 2022 EVP, Global Research and CSO
VRTX VERTEX PHARMACEUTICALS INC / MA Feb 17, 2022 6 -$1.8M 4 Feb 22, 2022 EVP, Global Research and CSO
VRTX VERTEX PHARMACEUTICALS INC / MA Feb 14, 2022 1 -$567K 4 Feb 16, 2022 EVP, Global Research and CSO
VRTX VERTEX PHARMACEUTICALS INC / MA Feb 10, 2022 5 -$1.38M 4 Feb 14, 2022 EVP, Global Research and CSO
VRTX VERTEX PHARMACEUTICALS INC / MA Feb 1, 2022 12 -$1.17M 4 Feb 3, 2022 EVP, Global Research and CSO
VRTX VERTEX PHARMACEUTICALS INC / MA Nov 15, 2021 2 -$6.37K 4 Nov 16, 2021 EVP, Global Research and CSO
VRTX VERTEX PHARMACEUTICALS INC / MA May 17, 2021 3 -$17.1K 4 May 19, 2021 EVP, Global Research and CSO